Johnson & Johnson Medical Devices
GPTKB entity
Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Biosense_Webster
Ethicon DePuy Cerenovus |
| gptkbp:awards |
Various Industry Awards
|
| gptkbp:CEO |
Joaquin Duato
|
| gptkbp:clinicalTrials |
Ongoing Research
|
| gptkbp:communityOutreach |
Disaster Relief Efforts
Health Education Programs Local Community Support Global_Health_Initiatives |
| gptkbp:corporateSocialResponsibility |
Accountability
Stakeholder Engagement Transparency Sustainable Development Goals Ethical Practices |
| gptkbp:employees |
Over 40,000
|
| gptkbp:focusArea |
Neuroscience
Orthopedics Cardiovascular Health Surgical Solutions Vision_Care Interventional_Solutions |
| gptkbp:founded |
1886
|
| gptkbp:globalPresence |
Over 60 Countries
|
| gptkbp:headquarters |
gptkb:New_Brunswick,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Johnson & Johnson Medical Devices
|
| gptkbp:innovation |
gptkb:Digital_Surgery
Robotic Surgery Minimally Invasive Surgery Advanced_Technologies |
| gptkbp:marketShare |
Leading Position
|
| gptkbp:operatesIn |
Global Market
|
| gptkbp:partnerships |
Government Agencies
Academic Institutions Various Healthcare Organizations Healthcare_Providers Non-Profit_Organizations |
| gptkbp:partOf |
gptkb:Johnson_&_Johnson
|
| gptkbp:products |
Orthopedic Devices
Surgical Instruments Cardiovascular Devices Neurosurgical_Devices |
| gptkbp:regulatoryCompliance |
FDA_Approved
CE_Mark_Certified |
| gptkbp:researchAndDevelopment |
Significant Investment
|
| gptkbp:revenue |
$26 billion (2020)
|
| gptkbp:supplyChain |
Quality Control
Supplier Relationships Sourcing and Procurement Global_Supply_Chain_Management Logistics_and_Distribution |
| gptkbp:sustainabilityInitiatives |
Community Engagement
Diversity and Inclusion Environmental Responsibility Product Stewardship |
| gptkbp:website |
www.jnjmedicaldevices.com
|